Blood-thinner to treat heart disease proves ineffective for many South Asian patients due to a mutation in their DNA
More than half of those with Bangladeshi and Pakistani ancestry have a genetic mutation that stops the drug clopidogrel from working properly, a study suggests.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Bangladesh Health | Cardiology | Clopidogrel | Genetics | Health | Heart | Heart Disease | Pakistan Health | Plavix | Study